Peter Nussbaumer

Managing Director at Lead Discovery Center GmbH, Lead Discovery Center GmbH

Professional Translational Research: a New Hybrid Paradigm in Early Drug Discovery

Early drug discovery (eDD) is undergoing a radical change with a strong trend of industry leaving and academia pushing into this field. Academia is a rich source of innovation for new therapeutic concepts and can contribute significant modules to drug discovery. However, most academic drug discovery initiatives lack the infrastructure and know-how for professional optimization of essential drug properties beyond potency, and successful direct collaboration with industry needs a substantial cultural change. Professional translational research centers (TRCs) are a new efficient paradigm to advance basic research results and hypotheses into industrial development and clinical application.
Go to the profile of Peter Nussbaumer
Nov 16, 2015